Literature DB >> 22210275

Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review.

Adriana R Fonseca1, Sheila K F de Oliveira, Marta C F Rodrigues, Ierecê L Aymoré, Romeu C Domingues, Flavio R Sztajnbok.   

Abstract

Relapsing polychondritis (RP) is a rare autoimmune systemic disease, especially in childhood. To report three new pediatric RP cases, to provide a literature review and to compare with adulthood disease, retrospective data collection from three childhood RP cases was observed in a Brazilian Pediatric Rheumatology Division. A literature review based on a MEDLINE database search was performed. Arthritis and auricular chondritis were present in our three patients. Two cases presented with early and severe laryngotracheal chondritis, besides initial and symptomatic costochondritis. The other case developed prominent epiphyseal plate involvement. Two patients were refractory to corticosteroids and immunosuppressants and required the use of TNF-alpha inhibitors to improve the symptoms, while corticosteroids plus methotrexate induced remission in the other patient. The literature review showed 44 cases of pediatric-onset disease in English language. Arthritis and ear chondritis are the most common initial and cumulative manifestations of RP in children and adults. Nasal and laryngotracheobronchial chondritis are also common manifestations observed during follow-up in childhood. There is also an early severity of respiratory chondritis in childhood, requiring aggressive treatment with corticosteroids, immunosuppressants and biologic agents. The data presented by those 3 children, considered in conjunction with the data from the 44 published cases, may reflect some distinguishing childhood RP features, such as more severe and frequent respiratory tract involvement, symptomatic costochondritis and the atypical pattern of persistent and destructive arthritis with epiphyseal plate involvement. Response to immunosuppressants and biologic agents is anecdotal, but steroids remain the main drug during the flares.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22210275     DOI: 10.1007/s00296-011-2336-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Ear, nose and throat manifestations of relapsing polychondritis in a child.

Authors:  F A Fadl; K M Hassan; N M Oyetunji; S A Al-Nour
Journal:  Saudi Med J       Date:  2001-08       Impact factor: 1.484

Review 2.  Pulmonary manifestations of relapsing polychondritis.

Authors:  Samaan Rafeq; David Trentham; Armin Ernst
Journal:  Clin Chest Med       Date:  2010-06-20       Impact factor: 2.878

3.  Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins.

Authors:  B Terrier; A Aouba; B Bienvenu; C Bloch-Queyrat; E Delair; J Mallet; A Mahr; L Guillevin
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

4.  Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients.

Authors:  M Zeuner; R H Straub; G Rauh; E D Albert; J Schölmerich; B Lang
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

5.  Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis.

Authors:  F Kempta Lekpa; J C Piette; S Bastuji-Garin; V B Kraus; T V Stabler; A R Poole; A Marini-Portugal; X Chevalier
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

Review 6.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

7.  Relapsing polychondritis--report of ten cases.

Authors:  J M Damiani; H L Levine
Journal:  Laryngoscope       Date:  1979-06       Impact factor: 3.325

8.  Joint symptoms in relapsing polychondritis.

Authors:  A Balsa; A Expinosa; M Cuesta; T I MacLeod; J Gijón-Baños; P J Maddison
Journal:  Clin Exp Rheumatol       Date:  1995 Jul-Aug       Impact factor: 4.473

9.  Relapsing polychondritis with segmental necrotizing glomerulonephritis.

Authors:  A Botey; M Navasa; A del Olmo; J Montoliu; O Ferrer; A Cardesa; A Darnell; L Revert
Journal:  Am J Nephrol       Date:  1984       Impact factor: 3.754

10.  Relapsing polychondritis in a child with common variable immunodeficiency.

Authors:  Neslihan Edeer Karaca; Guzide Aksu; Basak Yildiz; Nesrin Gulez; Bengu Turk; Tugrul Dereli; Necil Kutukculer
Journal:  Int J Dermatol       Date:  2009-05       Impact factor: 2.736

View more
  8 in total

Review 1.  Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

Authors:  Antonio Vitale; Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Francesco Molinaro; Mario Messina; Florenzo Iannone; Luca Cantarini
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

2.  Patient-perceived Burden of Disease in Pediatric Relapsing Polychondritis.

Authors:  Casey A Rimland; Marcela A Ferrada; Ninet Sinaii; Keith A Sikora; Robert A Colbert; Peter C Grayson; James D Katz
Journal:  J Rheumatol       Date:  2019-05-01       Impact factor: 4.666

3.  Three Cases of Relapsing Polycondritis with Isolated Laryngotracheal Stenosis.

Authors:  Hamdi Taşlı; Hakan Birkent; Mustafa Gerek
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-06-01

4.  Relapsing polychondritis: clinical presentations, disease activity and outcomes.

Authors:  Aman Sharma; Arjun Dutt Law; Pradeep Bambery; Vinay Sagar; Ajay Wanchu; Varun Dhir; Rajesh Vijayvergiya; Kusum Sharma; Ashok Gupta; Naresh K Panda; Surjit Singh
Journal:  Orphanet J Rare Dis       Date:  2014-12-20       Impact factor: 4.123

5.  Relapsing polychondritis: state of the art on clinical practice guidelines.

Authors:  Simona Rednic; Laura Damian; Rosaria Talarico; Carlo Alberto Scirè; Alexander Tobias; Nathalie Costedoat-Chalumeau; David Launay; Alexis Mathian; Lisa Mattews; Cristina Ponte; Paola Toniati; Stefano Bombardieri; Charissa Frank; Matthias Schneider; Vanessa Smith; Maurizio Cutolo; Marta Mosca; Laurent Arnaud
Journal:  RMD Open       Date:  2018-10-18

6.  Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis: A systematic review.

Authors:  Josette Biya; Sandra Dury; Jeanne-Marie Perotin; Claire Launois; Maxime Dewolf; Gaëtan Deslée; François Lebargy
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.889

7.  Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis.

Authors:  Saskia R Veldkamp; Marc H A Jansen; Joost F Swart; Caroline A Lindemans
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

8.  Relapsing polychondritis causing breathlessness: Two case reports.

Authors:  Song-Yu Zhai; Yu-Hao Zhang; Ru-Yan Guo; Jie-Wen Hao; Shu-Xin Wen
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.